City of Hope-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:City of Hope - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014050
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
City of Hope (COH) is a biomedical research organization that offers cancers, diabetes and infectious diseases treatment services. The organization offers services in the fields of anesthesiology, interventional radiology, surgery, donor matching and marrow transplants, rehabilitation services and pathology, among others. It conducts research and development to develop treatments for cancer fighting drugs, avastin, herceptin, and rituxan. COH also offers educational services for post doctoral fellowships through its affiliates. The organization also provides clinical trial services. Its community practice site includes Arcadia, Corona, Mission Hills, Arcadia Radiation Oncology, Santa Clarita, Palm Springs, Simi Valley, Colton, Glendora, Pasadena, and others. The orgaization operates in Duarte, Rancho Cucamonga, Simi Valley, Santa Clarita, Mission Hills, Pasadena, Arcadia, Glendora, and West Covina. COH is headquartered in Duarte, California, the US.

City of Hope – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
City of Hope, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
City of Hope, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
City of Hope, Medical Devices Deals, 2011 to YTD 2017 10
City of Hope, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
City of Hope, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Helocyte Enters into Agreement with City of Hope for PepVax 13
Helocyte Enters into Agreement with City of Hope 14
Sorrento Therapeutics forms Joint Venture with City of Hope 15
Coronado Biosciences Forms Joint Venture with City of Hope 16
ModiQuest Research Enters Into Research Agreement With Beckman Research Institute 17
Licensing Agreements 18
Mustang Bio Enters into Licensing Agreement with City of Hope 18
City of Hope Signs Licensing Agreement with Homology Medicines 19
Helocyte Exercises Option for Licensing Agreement with City of Hope for Pentamer 20
Mustang Bio Enters into Licensing Agreement with City of Hope 21
Helocyte Amends Agreement with City of Hope National Medical Center 22
Akriveia Therapeutics Enters into Licensing Agreement with City of Hope and Thomas Jefferson University 23
Beckman Research Institute Enters into Licensing Agreement with CEVEC Pharma 24
Tara Immuno-Oncology Therapeutics Enters into Licensing Agreement with City of Hope 25
Sorrento Therapeutics Enters into Licensing Agreement with City of Hope 26
Novonco Pharma Enters into Licensing Agreement with City of Hope 27
ES Cell International Enters into Licensing Agreement with Beckman Research Institute 28
City of Hope – Key Competitors 29
City of Hope – Key Employees 30
City of Hope – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 34
Government and Public Interest 34
Apr 17, 2017: City Of Hope Researchers Successfully Prevent Graft-Versus-Host Disease While Preserving Strong Graft Versus Leukemia Effects In Preclinical Study 34
Mar 07, 2017: Researchers Study Cure for Type 1 Diabetes in Stem Cell Transplantations 36
Sep 12, 2016: Semma Therapeutics Announces $5 Million Grant from California Institute of Regenerative Medicine to Develop Novel Stem-Cell Derived Treatment for Diabetes 37
Jun 29, 2016: Study Recommends Genomic Profiling to Diagnose Nonsmall Cell Lung Cancer Subtypes 38
Apr 03, 2016: Salmonella-Based Oral Vaccine Is A Potential Therapy For Preventing Type 1 Diabetes 40
Mar 31, 2016: City Of Hope awarded $2.5 million grant by the Conrad N. Hilton Foundation to launch nutrition initiative 41
Mar 16, 2016: City of Hope Research Team Receives $7.38 Million Grant from California’s Stem Cell Agency 43
Mar 03, 2016: City of Hope, Israel Cancer Research Fund Create Program for Cancer Research 44
Feb 08, 2016: City of Hope Scientists Create Technology to Target ‘Undruggable’ Diseases 45
Jan 21, 2016: City of Hope Receives $12 Million NCI Grant Supporting Innovative Cloud-Based Approach 46
Product News 47
May 01, 2017: City of Hope Researchers Find Regular Use of Aspirin Can Lower Risk of Breast Cancer for Women 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
City of Hope, Pharmaceuticals & Healthcare, Key Facts 2
City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
City of Hope, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
City of Hope, Deals By Therapy Area, 2011 to YTD 2017 9
City of Hope, Medical Devices Deals, 2011 to YTD 2017 10
City of Hope, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Helocyte Enters into Agreement with City of Hope for PepVax 13
Helocyte Enters into Agreement with City of Hope 14
Sorrento Therapeutics forms Joint Venture with City of Hope 15
Coronado Biosciences Forms Joint Venture with City of Hope 16
ModiQuest Research Enters Into Research Agreement With Beckman Research Institute 17
Mustang Bio Enters into Licensing Agreement with City of Hope 18
City of Hope Signs Licensing Agreement with Homology Medicines 19
Helocyte Exercises Option for Licensing Agreement with City of Hope for Pentamer 20
Mustang Bio Enters into Licensing Agreement with City of Hope 21
Helocyte Amends Agreement with City of Hope National Medical Center 22
Akriveia Therapeutics Enters into Licensing Agreement with City of Hope and Thomas Jefferson University 23
Beckman Research Institute Enters into Licensing Agreement with CEVEC Pharma 24
Tara Immuno-Oncology Therapeutics Enters into Licensing Agreement with City of Hope 25
Sorrento Therapeutics Enters into Licensing Agreement with City of Hope 26
Novonco Pharma Enters into Licensing Agreement with City of Hope 27
ES Cell International Enters into Licensing Agreement with Beckman Research Institute 28
City of Hope, Key Competitors 29
City of Hope, Key Employees 30
City of Hope, Other Locations 32
City of Hope, Subsidiaries 32
City of Hope, Joint Venture 33

★海外企業調査レポート[City of Hope-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QuadGraphics, Inc. (QUAD):企業の財務・戦略的SWOT分析
    QuadGraphics, Inc. (QUAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Illinois Tool Works Inc.:企業のM&A・事業提携・投資動向
    Illinois Tool Works Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Illinois Tool Works Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Cellestia Biotech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Cellestia Biotech AG (Cellestia Biotech) is a biopharmaceutical company that develops anti-cancer drugs for the treatment of oncology and immunological disorders. The company's lead compound includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymp …
  • American National Insurance Co:企業の戦略・SWOT・財務情報
    American National Insurance Co - Strategy, SWOT and Corporate Finance Report Summary American National Insurance Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bangkok Bank Public Co Ltd:企業のM&A・事業提携・投資動向
    Bangkok Bank Public Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bangkok Bank Public Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • X4 Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary X4 Pharmaceuticals Inc (X4 Pharma) is a clinical stage biotechnology company that develops novel therapeutics to treat cancer and rare diseases. The company’s lead drug candidate, X4P-001-LD, is in Phase 2/3 trial used for the treatment for patients with WHIM and other immunodeficiencies. It …
  • MAN SE:企業の戦略・SWOT・財務分析
    MAN SE - Strategy, SWOT and Corporate Finance Report Summary MAN SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Anagenesis Biotechnologies:製薬・医療:M&Aディール及び事業提携情報
    Summary Anagenesis Biotechnologies is a pharmaceutical solutions provider that offers treatment for muscle degenerative diseases. The company provides cell therapy genetics and pharmacological drugs for genetic and age related diseases. It also carries out cell-based technologies to provide solution …
  • Genalyte Inc-医療機器分野:企業M&A・提携分析
    Summary Genalyte Inc (Genalyte) is a healthcare service provider that develops cancer biomarker panels and testing platforms for screening. The company provides technologies such as the Maverick Detection System and Silicon Photonics Biosensor technology. Its Maverick Detection System quantifies the …
  • Petro Vista Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Petro Vista Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Petro Vista Energy Corp (Petro Vista) is an oil and gas company that offers oil and gas exploration and development services. The company offers acquisition, development, exploration, and product …
  • Tiscali Group:企業の戦略・SWOT・財務情報
    Tiscali Group - Strategy, SWOT and Corporate Finance Report Summary Tiscali Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Enauta Participacoes SA (QGEP3):企業の財務・戦略的SWOT分析
    Summary Enauta Participacoes SA (Enauta), a subsidiary of Queiroz Galvao Group, is an oil and gas company that explores, develops and produces oil and gas properties. The company's exploration properties include Santos Basin, Espirito Santo Basin, Camamu-Almada Basin, Sergipe-Alagoas Basin, Pernambu …
  • Acorn Energy, Inc. (ACFN):企業の財務・戦略的SWOT分析
    Acorn Energy, Inc. (ACFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Credit Suisse Group AG:企業のM&A・事業提携・投資動向
    Credit Suisse Group AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Credit Suisse Group AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Jubilee General Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Immupharma Plc (IMM):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmuPharma Plc (ImmuPharma) develops novel drugs for the treatment of serious medical conditions with unmet medical need. ImmuPharma develops drugs for the treatment of lupus, cancer, moderate to severe pain, highly resistant hospital-acquired infections such as methicillin-resistant staphyl …
  • Rothschild & Co SCA:企業の戦略・SWOT・財務分析
    Rothschild & Co SCA - Strategy, SWOT and Corporate Finance Report Summary Rothschild & Co SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • JRI Orthopaedics Ltd:企業の製品パイプライン分析2018
    Summary JRI Orthopaedics Ltd (JRI) a subsidiary of Orthopaedic Research UK (ORUK), is a manufacturer of orthopaedic implants and surgical instruments. The company develops products for joint replacement, repair and reconstruction. It offers products for shoulder and knee arthoplasty, besides customi …
  • Hycor Biomedical Inc-医療機器分野:企業M&A・提携分析
    Summary Hycor Biomedical Inc (Hycor) is a medical device company that manufactures and markets in-vitro diagnostic products. The company offers products such as auto immune testing systems, allergy testing systems, HYTEC plus and HYCOR ultrasensitive EIA products. Its auto immune testing products co …
  • Targovax ASA (TRVX):企業の財務・戦略的SWOT分析
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG01, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipelin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆